Complexa, Inc is a platform anti-inflammatory company utilizing endogenous mediators that signal the body's main anti-inflammatory pathways
Complexa, Inc is a platform anti-inflammatory company utilizing endogenous mediators that signal the body's main anti-inflammatory pathways. The company’s lead compound is scheduled to enter the clinic in 3Q13 to treat a form of kidney disease.